These data indicated that UCP2 dysfunction may confer chemoresistance through ROS-mediated Nrf2 stabilization and the consequent upregulation of the drug efflux transporter ABCG2 in NSCLC cells. This evidence concerns the gene UCP2 and non-small cell lung carcinoma.